Evidence map›Paper›PMID 26649827›Full record

ArticleNature2015

Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection.

Jacqueline M Kimmey, Jeremy P Huynh, Leslie A Weiss, Sunmin Park, Amal Kambal, Jayanta Debnath, Herbert W Virgin, Christina L Stallings

Abstract read
In one paragraph

Article in Nature, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 268 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
268citing papers in PubMed, 1 pooled it
28.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

268 citing papers in PubMed, 1 synthesis or guideline pooled it, 380 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Diverse infection models demonstrate robust resistance ofbioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Review
  10. Ly6GeLife · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

208 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jacqueline M KimmeyDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Jeremy P HuynhDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Leslie A WeissDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Sunmin ParkDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Amal KambalDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Jayanta DebnathDepartment of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California 94143, USA.
Herbert W VirginDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Christina L StallingsDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Washington University in St. Louis · USUCSF Helen Diller Family Comprehensive Cancer Center · US

Funding

Genetic and Pathway Analysis CoreU19AI109725 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 2014 to 2018
$32.7M
TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
NIAID NIH HHS U19 AI109725NIGMS NIH HHS GM007067NIGMS NIH HHS T32 GM007067
6 · The paper itself

Abstract

Mycobacterium tuberculosis, a major global health threat, replicates in macrophages in part by inhibiting phagosome-lysosome fusion, until interferon-γ (IFNγ) activates the macrophage to traffic M. tuberculosis to the lysosome. How IFNγ elicits this effect is unknown, but many studies suggest a role for macroautophagy (herein termed autophagy), a process by which cytoplasmic contents are targeted for lysosomal degradation. The involvement of autophagy has been defined based on studies in cultured cells where M. tuberculosis co-localizes with autophagy factors ATG5, ATG12, ATG16L1, p62, NDP52, BECN1 and LC3 (refs 2-6), stimulation of autophagy increases bacterial killing, and inhibition of autophagy increases bacterial survival. Notably, these studies reveal modest (~1.5-3-fold change) effects on M. tuberculosis replication. By contrast, mice lacking ATG5 in monocyte-derived cells and neutrophils (polymorponuclear cells, PMNs) succumb to M. tuberculosis within 30 days, an extremely severe phenotype similar to mice lacking IFNγ signalling. Importantly, ATG5 is the only autophagy factor that has been studied during M. tuberculosis infection in vivo and autophagy-independent functions of ATG5 have been described. For this reason, we used a genetic approach to elucidate the role for multiple autophagy-related genes and the requirement for autophagy in resistance to M. tuberculosis infection in vivo. Here we show that, contrary to expectation, autophagic capacity does not correlate with the outcome of M. tuberculosis infection. Instead, ATG5 plays a unique role in protection against M. tuberculosis by preventing PMN-mediated immunopathology. Furthermore, while Atg5 is dispensable in alveolar macrophages during M. tuberculosis infection, loss of Atg5 in PMNs can sensitize mice to M. tuberculosis. These findings shift our understanding of the role of ATG5 during M. tuberculosis infection, reveal new outcomes of ATG5 activity, and shed light on early events in innate immunity that are required to regulate disease pathology and bacterial replication.

Indexed as

Mycobacterium tuberculosisAnimalsAutophagyAutophagy-Related Protein 5Dendritic CellsFemaleImmunity, InnateInterferon-gammaMacrophages, AlveolarMaleMiceMicrotubule-Associated ProteinsNeutrophilsTuberculosisAtg5 protein, mouseAutophagy-Related Protein 5Interferon-gammaMicrotubule-Associated Proteins

Identifiers

PMID26649827
PMCPMC4842313
OpenAlexW2192964424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.